Skip to main content
The First Patient in the Veteran Affairs System to Receive Chimeric Antigen Receptors T-cell Therapy for Refractory Multiple Myeloma and the Role of Intravenous Immunoglobulin in the Prevention of Therapy-associated Infections
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
The First Patient in the Veteran Affairs System to Receive Chimeric Antigen Receptors T-cell Therapy for Refractory Multiple Myeloma and the Role of Intravenous Immunoglobulin in the Prevention of Therapy-associated Infections
User login
Username
Password
Reset your password
Specialty
Lead
score
Hematology-Oncology
1
0.98
Allergy & Clinical Immunology
0
0.91
Pharmacist
0
0.68
Family Medicine/Primary Care
0
0.43
Concept
Lead
score
Multiple Myeloma
1
1
CAR-T
0
1
Biologic Therapy
0
0.99
Intravenous Immunoglobulin (IVIG)
0
0.51
Immunoglobulin A (IgA)
0
0.38
Hypogammaglobulinemia
0
0.32
Refractory
0
0.32
Antigens
0
0.26
Intravenous
0
0.26
Receptors
0
0.26
Edit Tags